Rafferty Asset Management, LLC
Position in EBS — Emergent BioSolutions Inc.
CIK 1389426
New York, NY
Position in EBS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$397,463
-$309,688 QoQ
Shares Held
47,430
-44.3% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 194 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $21,876,011 across 22 Drug Manufacturers - Specialty & Generic names. EBS ranks #9 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
48,590 | $3,491,677 | |
| 2 | ALKS |
Alkermes plc.
|
62,965 | $3,299,366 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
18,743 | $3,158,945 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
5,742 | $3,111,187 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
265,618 | $2,656,180 | |
| 6 | VTRS |
Viatris Inc
|
140,790 | $2,235,745 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
152,878 | $643,616 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
16,555 | $407,418 |
All Filings in EBS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $397,463 | 47,430 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $707,151 | 85,199 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,100,262 | 89,018 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $831,029 | 94,221 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $497,046 | 77,907 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $539,946 | 111,100 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,383,523 | 144,720 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,202,575 | 144,021 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $4,274,943 | 581,625 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,968,781 | 383,087 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,908,141 | 415,592 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,932,293 | 234,983 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,964,646 | 127,727 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,020,545 | 146,628 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,723,477 | 131,665 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,733,321 | 54,590 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,586,999 | 41,070 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,432,652 | 36,946 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $998,054 | 11,139 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,090,469 | 20,231 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,303,001 | 16,477 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $269,454 | 4,657 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||